![]() |
|
|
Vol. 293, Issue 3, 807-812, June 2000
Department of Pharmacology, Joan & Sanford I. Weill Medical College
of Cornell University, New York, New York
Serum is required for the survival and growth of most animal cells. In
serum-free medium, B lymphoblastoid cells and fibroblasts die after 2 days. We report that submicromolar concentrations of
9-tetrahydrocannabinol (THC),
8-THC,
cannabinol, or cannabidiol, but not WIN 55,212-2, prevented serum-deprived cell death.
9-THC also synergized with
platelet-derived growth factor in activating resting NIH 3T3
fibroblasts. The cannabinoids' growth supportive effect did not
correlate with their ability to bind to known cannabinoid receptors and
showed no stereoselectivity, suggesting a nonreceptor-mediated pathway.
Direct measurement of oxidative stress revealed that cannabinoids
prevented serum-deprived cell death by antioxidation. The antioxidative
property of cannabinoids was confirmed by their ability to antagonize
oxidative stress and consequent cell death induced by the retinoid
anhydroretinol. Therefore, cannabinoids act as antioxidants to modulate
cell survival and growth of B lymphocytes and fibroblasts.
This article has been cited by other articles:
![]() |
M. Rajesh, P. Mukhopadhyay, S. Batkai, G. Hasko, L. Liaudet, V. R. Drel, I. G. Obrosova, and P. Pacher Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H610 - H619. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pacher, S. Batkai, and G. Kunos The Endocannabinoid System as an Emerging Target of Pharmacotherapy Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Kim, S. J. Won, X. O. Mao, K. Jin, and D. A. Greenberg Involvement of Protein Kinase A in Cannabinoid Receptor-Mediated Protection from Oxidative Neuronal Injury J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 88 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Amtmann, P. Weydt, K. L. Johnson, M. P. Jensen, and G. T. Carter Survey of cannabis use in patients with amyotrophic lateral sclerosis American Journal of Hospice and Palliative Medicine, March 1, 2004; 21(2): 95 - 104. [Abstract] [PDF] |
||||
![]() |
R. R. Leker, N. Gai, R. Mechoulam, and H. Ovadia Drug-Induced Hypothermia Reduces Ischemic Damage: Effects of the Cannabinoid HU-210 Stroke, August 1, 2003; 34(8): 2000 - 2006. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Steinborn, A. K. Chinn, and G. T. Carter The latest buzz on medicinal marijuana: A legal and medical perspective American Journal of Hospice and Palliative Medicine, September 1, 2001; 18(5): 295 - 298. [PDF] |
||||
![]() |
G. T. Carter and B. S. Rosen Marijuana in the management of amyotrophic lateral sclerosis American Journal of Hospice and Palliative Medicine, July 1, 2001; 18(4): 264 - 270. [Abstract] [PDF] |
||||